Global Cerebral Somatic Oximeters Market Report and Forecast 2025-2034

Global Cerebral Somatic Oximeters Market Outlook

The global cerebral somatic oximeters market is expected to grow at a CAGR of 7.5% during the period 2025-2034. North America, Europe and Asia are likely to be key markets.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Market Likely to be Driven by Need for Reliable Monitoring to Prevent Adverse Events and Enhance Patient Care and Outcomes

The global cerebral somatic oximeters market is likely to be driven by the need for dependable monitoring to avoid adverse events and improve patient care and outcomes.

Leading companies offer sophisticated solutions for better patient outcomes. For example, the INVOS™ system offers clinicians with reliable, timely, and actionable monitoring to help prevent adverse events and enhance patient care and outcomes. INVOS™ system technology offers a non-invasive “window” to the body’s microvasculature; a direct and dynamic site of gas exchange that transports about half the body’s blood volume. Gauging blood oxygenation in the microvasculature leads to sensitive and site-specific insights on perfusion adequacy or – with multi-sensor monitoring – perfusion distribution across the brain and body.

Features of the solution include near infrared spectroscopy (NIRS) to monitor Regional Oxygen Saturation (rSO2); supported by more than 600 peer reviewed papers; accurate value based on 75% Venous to 25% Arterial saturation. Benefits include detection of subtle changes in Saturation and Cerebral perfusion; reduction in major organ morbidity or mortality, ICU and Hospital length of Stay, Stroke, Renal failure and Postoperative cognitive decline.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Advanced Solutions by Leading Companies Expected to Drive Market Growth

Sophisticated solutions by leading companies are likely to boost growth of global cerebral somatic oximeters market. For example, the INVOS™ system is the only cerebral/somatic oximetry system with FDA cleared improved outcome claims. The INVOS™ system offers real-time monitoring of changes in regional oxygen saturation (rSO2) of blood in the brain or other body tissues under the sensor for effective oxygen monitoring in adults, children, infants and neonates. The system enables clinicians to measure site-specific oxygen levels rather than requiring them to infer the data from systemic, whole-body measures such as blood pressure and pulse oximetry. It comes in two or four data channels, and clinicians can conveniently monitor multiple brain and body areas.

Features of INVOS™ 5100C Cerebral/Somatic Oximeter include monitoring the stability of cerebral and peripheral circulations in a non-invasive, real-time way; leveraging associations between cerebral and peripheral circulations to better manage care; enables clinicians to identify if vascular beds around the vital organ areas are sufficiently perfused; enables clinicians to more closely recognize and manage regional oxygenation issues in the O.R., PICU, NICU and/or cardiac catheter lab; assists clinicians gather objective data noninvasively for decision making; suitable for patients of any weight or age.

Nonin cerebral and tissue (regional) oximetry systems assess rSO2 and offer precise, steady measurements of tissue oxygen saturation for real-time management of patients at risk for compromised oxygen saturation to the brain and other tissues. Nonin universal oximetry systems measure rSO2, SpO2, and pulse rate at the same time. Nonin regional oximetry systems are devised for use in cerebral as well as somatic positions, and may be employed for spot-checking or continuous monitoring of neonatal, paediatric, or adult patients in hospitals, long-term care, medical facilities, sleep laboratories and sub-acute environments.

Market Segmentation

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By type, the market is segmented into:

• Single Emitter and Dual Detector
• Dual Emitter and Dual Detector
• Others

By application, the market is divided into:

• Cardiac Surgery
• Vascular Surgery
• Others

By patient type, the market is segmented into:

• Paediatrics
• Adults

By end user, the market is classified into:

• Hospitals and Clinics
• Ambulatory Surgical Centres
• Others

By region, the market is segmented into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Key Industry Players in the Market

The report presents a detailed analysis of the following key players in the global cerebral somatic oximeters market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Medtronic Plc
• Nonin Medical, Inc.
• Masimo
• Edwards Lifesciences Corporation
• Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report